HER2 and CD24 Emerge as Promising Radiotheranostic Targets in Endometrial Cancer

-
Image
  HER2 and CD24 Emerge as Promising Radiotheranostic Targets in Endometrial Cancer Introduction Endometrial cancer, the most common gynecological cancer in developed countries, has been steadily rising in incidence worldwide. While early-stage disease often responds well to surgery and conventional therapies, advanced and recurrent cases remain challenging to treat. Over the last decade, researchers have been exploring precision oncology strategies—approaches that target specific molecular markers in cancer cells to improve outcomes. Among these emerging strategies is radiotheranostics , a cutting-edge field that combines diagnostic imaging and targeted radionuclide therapy. The idea is simple yet powerful: use the same molecule to both detect and destroy cancer cells. Recent studies highlight two promising molecular candidates for radiotheranostic development in endometrial cancer— HER2 (human epidermal growth factor receptor 2) and CD24 , a cell surface glycoprotein. In t...
Post a Comment

Common Blood Pressure Medication Linked to Increased Skin Cancer Risk, Study Finds

-

 

Common Blood Pressure Medication Linked to Increased Skin Cancer Risk, Study Finds



Introduction

High blood pressure, also known as hypertension, is one of the most common chronic conditions worldwide. Millions of people rely on daily medications to keep their blood pressure under control and reduce risks of heart attacks, strokes, and kidney problems. However, a new study has raised concerns about a possible link between certain blood pressure medications and an increased risk of skin cancer.

This discovery has sparked widespread discussion in the medical community and among patients. While the benefits of treating high blood pressure remain undeniable, researchers are urging caution, more research, and stronger sun protection habits for those taking specific drugs. In this article, we’ll explore the details of the study, the types of medication involved, the potential biological reasons for this link, and what patients should do moving forward.

Understanding Blood Pressure Medications

Blood pressure drugs are not a one-size-fits-all treatment. Doctors prescribe different classes of medications depending on a patient’s health profile, age, and severity of hypertension. The most commonly prescribed categories include:

  • Diuretics – help the body get rid of excess salt and water.

  • ACE inhibitors – relax blood vessels by blocking a hormone that tightens them.

  • ARBs (angiotensin receptor blockers) – work similarly to ACE inhibitors.

  • Beta-blockers – reduce the workload on the heart and open blood vessels.

  • Calcium channel blockers – prevent calcium from entering heart and blood vessel cells, making them relax.

Among these, a particular subgroup has now been linked to a higher risk of skin cancer in several studies.

The New Study and Its Findings

The recent research, published in a reputable medical journal, analyzed data from thousands of patients over several years. Scientists compared skin cancer diagnoses with the use of antihypertensive drugs, particularly hydrochlorothiazide (HCTZ), one of the most widely used diuretics.

The results revealed a significant increase in non-melanoma skin cancers among long-term users of hydrochlorothiazide. This includes:

  • Basal cell carcinoma (BCC) – the most common form of skin cancer.

  • Squamous cell carcinoma (SCC) – a more aggressive but still treatable form.

The risk appeared to be dose-dependent, meaning the longer a person took the medication and the higher the cumulative dose, the greater the likelihood of developing skin cancer.

Why This Link Matters

High blood pressure is a global epidemic, with an estimated 1.28 billion adults worldwide suffering from the condition. Hydrochlorothiazide is often the first-line treatment because it is affordable, effective, and widely available.

If even a fraction of these patients face increased skin cancer risks, it could impact millions of people. However, it is important to stress that the overall risk is still relatively small compared to the dangers of untreated hypertension, which can lead to heart failure, strokes, and premature death.

The Biological Explanation: How Could Medication Cause Skin Cancer?

Researchers believe the connection between hydrochlorothiazide and skin cancer risk lies in the drug’s effect on sun sensitivity.

  • Photosensitivity: Hydrochlorothiazide makes the skin more sensitive to ultraviolet (UV) rays from the sun.

  • DNA Damage: Increased UV exposure without protection can lead to DNA mutations in skin cells.

  • Cumulative Effect: Over time, this DNA damage may accumulate, raising the chances of developing cancers such as BCC or SCC.

This explains why the risk appears higher in people living in sunny climates or those who spend a lot of time outdoors.

Other Studies Supporting This Link

This isn’t the first time scientists have suspected a connection between blood pressure medications and skin cancer. Several earlier studies have pointed in the same direction:

  • A Danish study found that patients taking high cumulative doses of hydrochlorothiazide had up to a seven-fold increase in squamous cell carcinoma risk.

  • Another study in the United States also reported a higher incidence of non-melanoma skin cancers among patients using thiazide diuretics.

  • Health agencies in Europe have already issued warnings and label updates for hydrochlorothiazide regarding this potential side effect.

Should Patients Stop Taking Their Medication?

The most important question patients may ask after hearing this news is: “Should I stop my blood pressure medicine?” The answer is no—at least not without consulting your doctor.

Here’s why:

  • The benefits outweigh the risks: Uncontrolled hypertension is far more dangerous than the slightly increased risk of skin cancer.

  • Alternative medications exist: If you have concerns, your doctor may suggest switching to another blood pressure drug that does not carry the same risk.

  • Monitoring and prevention work: With proper skin care, sun protection, and regular dermatology checkups, the risks can be managed.

Practical Steps for Patients on Hydrochlorothiazide

If you are currently taking hydrochlorothiazide or another thiazide diuretic, here are some steps to protect yourself:

1. Talk to Your Doctor

Never stop medication on your own. Ask your healthcare provider about your specific risk factors, medical history, and whether an alternative medication might be suitable.

2. Practice Sun Safety

  • Wear sunscreen daily, even on cloudy days.

  • Use a broad-spectrum sunscreen with SPF 30 or higher.

  • Wear protective clothing, wide-brimmed hats, and sunglasses.

  • Seek shade during peak UV hours (10 a.m. – 4 p.m.).

3. Check Your Skin Regularly

  • Look for new moles, growths, or patches of skin that change color, bleed, or don’t heal.

  • Visit a dermatologist for routine skin checks, especially if you have fair skin or a history of sunburns.

4. Maintain a Healthy Lifestyle

  • Manage blood pressure with a balanced diet, regular exercise, and reduced salt intake.

  • Avoid smoking and excessive alcohol use, both of which can worsen blood pressure and overall cancer risks.

Expert Opinions

Many medical experts are weighing in on this issue. Some argue that the risks are not high enough to warrant panic, while others believe it’s time to re-evaluate prescribing habits.

  • Dermatologists emphasize the importance of sun protection and regular skin checks.

  • Cardiologists stress that hypertension treatment must remain the priority, as cardiovascular risks are immediate and life-threatening.

  • Public health officials suggest adding stronger warnings and educational campaigns for patients using hydrochlorothiazide.

Global Health Implications

The potential link between a commonly prescribed drug and one of the most prevalent cancers has serious public health implications:

  • Regulatory action: Some countries may require updated labeling for hydrochlorothiazide.

  • Healthcare costs: Increased skin cancer cases could put additional strain on healthcare systems.

  • Awareness campaigns: Patients may need better education on sun safety, especially in regions with high UV exposure.

Balancing Risks and Benefits

Medicine often involves balancing risks against benefits. For hydrochlorothiazide:

  • Benefit: Proven to lower blood pressure, reduce strokes, and save lives.

  • Risk: Slightly increased chance of developing non-melanoma skin cancers.

For most patients, doctors agree that the benefits outweigh the risks, but individual cases may vary. The key lies in personalized medicine—choosing the right treatment for each patient’s unique situation.

Future Research

While current evidence is strong, scientists emphasize the need for more research. Upcoming studies may focus on:

  • The exact biological mechanisms linking hydrochlorothiazide to skin cancer.

  • Whether other diuretics or blood pressure drugs carry similar risks.

  • Genetic factors that might make certain individuals more vulnerable.

  • Effective strategies to mitigate risks while continuing treatment.

Conclusion

The discovery that a common blood pressure medication may increase skin cancer risk highlights the complexity of modern medicine. Hydrochlorothiazide remains an effective and widely used treatment, but patients should be aware of the potential risks and take proactive steps to protect their skin.

For anyone taking these medications, the best course of action is not to panic, but to stay informed, talk openly with healthcare providers, and adopt sun-safe habits. With proper awareness and medical guidance, it is possible to enjoy the life-saving benefits of blood pressure control while minimizing potential side effects.

Comments

Post a Comment

Popular posts from this blog

HER2 and CD24 Emerge as Promising Radiotheranostic Targets in Endometrial Cancer

-
Image
  HER2 and CD24 Emerge as Promising Radiotheranostic Targets in Endometrial Cancer Introduction Endometrial cancer, the most common gynecological cancer in developed countries, has been steadily rising in incidence worldwide. While early-stage disease often responds well to surgery and conventional therapies, advanced and recurrent cases remain challenging to treat. Over the last decade, researchers have been exploring precision oncology strategies—approaches that target specific molecular markers in cancer cells to improve outcomes. Among these emerging strategies is radiotheranostics , a cutting-edge field that combines diagnostic imaging and targeted radionuclide therapy. The idea is simple yet powerful: use the same molecule to both detect and destroy cancer cells. Recent studies highlight two promising molecular candidates for radiotheranostic development in endometrial cancer— HER2 (human epidermal growth factor receptor 2) and CD24 , a cell surface glycoprotein. In t...
Read more

LASIK Alternative Reshapes Vision with Electricity, Not Lasers

-
Image
  LASIK Alternative Reshapes Vision with Electricity, Not Lasers Introduction For decades, LASIK surgery has been the gold standard for correcting common vision problems like nearsightedness, farsightedness, and astigmatism. Millions of people have undergone laser eye surgery to reduce or eliminate their dependence on glasses and contact lenses. However, LASIK isn’t the right option for everyone. Some patients worry about risks, costs, or complications, while others may not qualify due to thin corneas or other health issues. Now, researchers and eye specialists are exploring a promising new alternative that could reshape the future of vision correction. Instead of relying on lasers to change the curvature of the cornea, this breakthrough technique uses electric fields to reshape vision—offering a less invasive and potentially safer solution. This emerging treatment, sometimes referred to as electro-refractive therapy , could transform how millions of people achieve clear sight...
Read more

Red Sox trade All-Star slugger Rafael Devers to Giants

-
Image
  In a surprising move, the Boston Red Sox have traded All-Star slugger Rafael Devers to the San Francisco Giants. The blockbuster deal was announced on Sunday, June 15, 2025. The Giants acquired Devers in exchange for a package of players that includes pitchers Jordan Hicks and Kyle Harrison, along with prospects James Tibbs III and Jose Bello. The Giants will also be taking on the entirety of Devers' substantial contract, which was a 10-year, $313.5 million extension he signed in 2023. atOptions = { 'key' : '8bbcbd6e4223cb98882d5e5e8684266c', 'format' : 'iframe', 'height' : 90, 'width' : 728, 'params' : {} }; t-icon _ngcontent-ng-c726712813="" aria-hidden="true" class="mat-icon notranslate symbol gds-icon-s google-symbols mat-ligature-font mat-icon-no-color" data-mat-icon-name="link" data-mat-icon-type="font" fonticon="link" role="img"...
Read more